This page explains more about Prevent Breast Cancer‘s research projects into preventative drugs. If you would like to donate directly to this research pillar to help fund this aspect of our work, please click here and choose ‘Preventative Drugs’ as the project.
Preventative drugs are a key research area for Prevent Breast Cancer. In some cases, people with a high risk of developing breast cancer may be able to take certain medications in order to make it less likely that they will get the disease in future.
Thanks to Prevent Breast Cancer researchers, there have been changes to NICE guidelines (July 2013), which mean that tamoxifen and raloxifene (drugs which are used in breast cancer treatment) are now recommended for women with an increased risk of breast cancer in order to help stop it developing.
Although they do benefit a large number of women, tamoxifen and raloxifene do come with difficult side effects and are not always successful. Therefore our teams continue to seek out safer and more effective preventative drugs.
Prevent Breast Cancer scientists are currently working on the following projects:
- DCIS and Clotting – this project examined the links between breast cancer and clotting in the blood.
- Hydrogel – our newest project uses state-of-the-art hydrogel technology to replicate accurate models of breast tissue which can then be used to humanely test new preventative drugs.
- Anti-Prolactin for Prevention – our researchers are looking at the effect of two hormones, progesterone and prolactin, and their effect on breast cell tissue samples. They hope the results may lead to more avenues for prevention.
Watch our charity’s Chairman Lester Barr explain more about this pillar of research at Prevent Breast Cancer in the video below:
If you would like to apply for a research grant, click here. Prevent Breast Cancer never fund research involving animals.